Figure 4.
BMOV treatment reduced pan‐PTP activity in metabolic tissues. Measurements of PTP activity were performed in liver (A), skeletal muscle (B) and adipose tissue (C) of BMOV treated mice compared to HFD mice. Crude protein lysates were used for activity measurement with a radioactive labelled peptide. †† P < 0.01 HFD vs. BMOV; ††† P < 0.001 HFD vs. BMOV; n = 10–11 for each group.